https://www.selleckchem.com/pr....oducts/bso-l-buthion
To characterize the pediatric super-refractory status epilepticus population by describing treatment variability in super-refractory status epilepticus patients and comparing relevant clinical characteristics, including outcomes, between super-refractory status epilepticus, and nonsuper-refractory status epilepticus patients. Retrospective cohort study with prospectively collected data between June 2011 and January 2019. Seventeen academic hospitals in the United States. We included patients 1 month to 21 years
Like
Comment
Share
